Standard Nuclear
STDN
14.21
-0.98
-6.45%
Standard Nuclear
US · STDN
#2777 by market cap
Listed 2026
14.21
-0.98
-6.45%
Live - 5344 symbols - heartbeat 397s ago
· 2026-10-08 04:00
Pre-market
14.21
0.00%
After-hours
14.48
+1.90%
Overnight
14.21
0.00%
- Market cap
- 2.22B
- P/E (TTM)i
- -132.80
- P/Bi
- -28.65
- EPSi
- -0.10
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on STDN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.27, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 2 years
Margins
- Gross margin
- -144.36%
- Operating margin
- -287.65%
- Net margin
- -494.92%
Key ratios & quality
- Altman Z-Scorei
- 8.27
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2024 | 2025 |
|---|---|---|
| Revenue | -- | 3.14M |
| Gross profit | -- | -4.53M |
| Selling & admin expenses | -- | 4.50M |
| Research & development | -- | 0 |
| Operating profit | -- | -9.03M |
| Pretax profit | -- | -15.54M |
| Tax | -- | 0 |
| Net profit | -- | -15.54M |
| Basic EPS | -- | 0 |
| Diluted EPS | -- | -0.10 |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Revenue | 377.93K | 552.94K | 593.80K | 4.74M |
| Gross profit | -742.58K | -629.75K | -4.41M | 3.18M |
| Selling & admin expenses | 671.21K | 1.01M | 3.83M | 5.52M |
| Research & development | -- | 0 | -- | 1.96M |
| Operating profit | -1.41M | -1.64M | -8.24M | -4.30M |
| Pretax profit | -8.29M | -1.63M | -7.71M | -3.42M |
| Tax | 0 | 0 | 0 | 0 |
| Net profit | -8.29M | -1.63M | -7.71M | -3.42M |
| Basic EPS | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.05 | -0.06 | -0.05 | -0.02 |
Balance sheet
| Line item | 2024 | 2025 |
|---|---|---|
| Total current assets | 1.62M | 65.39M |
| Cash & ST investments | 1.62M | 63.10M |
| Inventory | -- | -- |
| Total assets | 4.48M | 79.15M |
| Total current liabilities | 2.50M | 3.51M |
| Short-term debt | -- | -- |
| Long-term debt | -- | -- |
| Total liabilities | 60,796,820.00 | 149,266,739.00 |
| Total equity | -56.32M | -70.12M |
| Retained earnings | -56.60M | -72.14M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Total current assets | -- | -- | 126.95M | 113.10M |
| Cash & ST investments | -- | -- | 124.93M | 102.19M |
| Inventory | -- | -- | -- | -- |
| Total assets | -- | -- | 146.05M | 146.95M |
| Total current liabilities | -- | -- | 6.60M | 8.75M |
| Short-term debt | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- |
| Total liabilities | -- | -- | 222,370,119.00 | 224,542,799.00 |
| Total equity | -- | -- | -76.32M | -77.59M |
| Retained earnings | -- | -- | -79.85M | -83.27M |
Cash flow
| Line item | 2024 | 2025 |
|---|---|---|
| Operating cash flow | -- | -6.73M |
| Depreciation & amortization | -- | 271.79K |
| Free cash flow | -- | -15.66M |
| Dividends paid | -- | -- |
| Stock buybacks / issuance | -- | 0 |
| Ending cash balance | -- | 63.10M |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| Operating cash flow | -1.48M | -1.28M | -4.31M | -6.63M |
| Depreciation & amortization | 26.65K | 31.65K | 245.62K | 353.26K |
| Free cash flow | -1.66M | -1.66M | -8.18M | -20.18M |
| Dividends paid | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- |
| Ending cash balance | 7.91M | 6.25M | 124.93M | 102.19M |
Returns & efficiency
| Line item | 2024 | 2025 |
|---|---|---|
| ROE %i | -- | -- |
| ROA %i | -- | -37.17 |
| ROIC %i | -- | -- |
| 5-year avg ROE %i | -- | -- |
| EBIT margin %i | -- | -287.65 |
| FCF / sales %i | -- | -- |
| Current ratioi | 0.65 | 18.61 |
| Quick ratioi | 0.65 | 18.61 |
| Debt / assetsi | -- | -- |
| LT debt / equityi | -- | -- |
| Interest coveragei | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- |
| Net income CAGR (3Y) %i | -- | -- |
| FCF CAGR (3Y) %i | -- | -- |
| Line item | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- |
| ROA %i | -- | -- | -10.25 | -11.41 |
| ROIC %i | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -472.68 | -245.67 |
| FCF / sales %i | -- | -- | -- | -- |
| Current ratioi | -- | -- | 19.25 | 12.93 |
| Quick ratioi | -- | -- | 19.09 | 12.61 |
| Debt / assetsi | -- | -- | -- | -- |
| LT debt / equityi | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Service revenue100.00%
Quote time 2026-10-08 04:00:13 · For reference only, not investment advice and not tailored to your situation.